ClinicalTrials.Veeva

Menu
P

Paradigm Research Professionals, LLC | Oklahoma City, OK

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

SPN-812
Rapastinel
Viloxazine
SPN-810
Aticaprant
SPD489
Quetiapine XR
Oxycodone
Seltorexant
MK-1942

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 30 total trials

A Study of Aticaprant 10 Milligrams (mg) as Adjunctive Therapy in Adult Participants With MDD With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy (VENTURA-2)

The purpose of this study is to evaluate the efficacy of aticaprant compared with placebo as adjunctive therapy to an antidepressant in improving dep...

Enrolling
Depressive Disorder, Major
Anhedonia
Other: Placebo
Drug: Aticaprant

The purpose of this study is to assess the long-term safety and tolerability of aticaprant administered as adjunctive therapy to a current antidepres...

Enrolling
Depressive Disorder, Major
Drug: Aticaprant

Bipolar disorder is a severe chronic mood disorder that affects up to 4% of the adult population and 1.8% of the pediatric population in the United S...

Enrolling
Bipolar I Disorder
Depression
Drug: Placebo
Drug: Cariprazine

Open label extension, long-term multicenter study of safety and efficacy of SPN-812 in pediatric ADHD patients

Active, not recruiting
Attention-Deficit/Hyperactivity Disorder
Drug: SPN-812

Trial sponsors

Supernus Pharmaceuticals logo
Janssen (J&J Innovative Medicine) logo
Allergan logo
Otsuka logo
Pfizer logo
Shire logo
AbbVie logo
Forest Laboratories logo
Jazz Pharmaceuticals logo
Lundbeck logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems